Corline Biomedical AB | Balance Sheet
Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
1,178.80
1,644.80
4,867.80
11,864.00
16,856.00
Total Accounts Receivable
647.60
513.00
696.00
1,144.00
1,182.00
Other Current Assets
-
-
-
301.00
404.00
Total Current Assets
1,826.40
2,157.80
5,563.70
13,309.00
18,442.00
Net Property, Plant & Equipment
31.00
30.70
2.60
1.00
-
Total Investments and Advances
-
-
-
1.00
1.00
Intangible Assets
11,899.90
14,584.40
19,428.60
27,964.00
32,984.00
Total Assets
13,757.30
16,772.90
24,994.90
41,275.00
51,427.00
ST Debt & Current Portion LT Debt
3,547.00
9,312.50
-
-
-
Accounts Payable
31.70
139.10
1,601.20
768.00
3,235.00
Other Current Liabilities
1,919.10
1,836.60
2,143.40
1,761.00
2,266.00
Total Current Liabilities
5,497.80
11,288.10
3,744.60
2,529.00
5,501.00
Long-Term Debt
262.50
-
-
-
-
Total Liabilities
5,760.30
11,288.10
3,744.60
2,529.00
5,501.00
Common Equity (Total)
7,996.90
5,484.70
21,250.30
38,746.00
45,926.00
Total Shareholders' Equity
7,996.90
5,484.70
21,250.30
38,746.00
45,926.00
Total Equity
7,996.90
5,484.70
21,250.30
38,746.00
45,926.00
Liabilities & Shareholders' Equity
13,757.30
16,772.90
24,994.90
41,275.00
51,427.00
About Corline Biomedical AB
View Profile
